• Wed, April 10, 2024
Reni Benjamin Reiterated (BPMC) at Buy and Held Target at $114 on, Apr 10th, 2024
Reni Benjamin of JMP Securities, Reiterated "Blueprint Medicines Corporation" (BPMC) at Buy and Held Target at $114 on, Apr 10th, 2024.
Reni has made no other calls on BPMC in the last 4 months.
There are 7 other peers that have a rating on BPMC. Out of the 7 peers that are also analyzing BPMC, 1 agrees with Reni's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Peter Lawson of "Barclays" Maintained at Hold with Increased Target to $70 on, Tuesday, February 13th, 2024
These are the ratings of the 6 analyists that currently disagree with Reni
- Ami Fadia of "Needham" Reiterated at Strong Buy and Held Target at $97 on, Monday, February 26th, 2024
- David Lebowitz of "Citigroup" Maintained at Strong Sell with Increased Target to $65 on, Friday, February 16th, 2024
- Bradley Canino of "Stifel" Maintained at Strong Buy with Increased Target to $97 on, Tuesday, January 9th, 2024
- Dane Leone of "Raymond James" Maintained at Strong Buy with Increased Target to $100 on, Friday, December 22nd, 2023
- Derek Archila of "Wells Fargo" Maintained at Buy with Increased Target to $115 on, Tuesday, December 19th, 2023
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $85 on, Monday, December 11th, 2023
WOPRAI
Market Predictions Driven by AI
- Website: https://www.woprai.c ... ps://www.woprai.com/
- Email: support@woprai.com